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In mammals, homeostatic maintenance of energetic state is regulated by a sensory feedback system that attempts to preserve stability through the concerted modulation of both energy intake (as caloric consumption) and energy expenditure (as basal metabolism, adaptive thermogenesis and physical exertion). Ultimately, unbalancing of this equation is reflected by alterations in body weight, with a positive (intake > expenditure) or negative (intake < expenditure) energy balance engendering weight gain or loss, respectively. Although acute fluctuations in the relative levels of energy intake and expenditure are tolerated and redressed, chronic destabilization can have severe implications for health 1 and longevity 2 . Furthermore, energy balance regulation biases toward defense against the lower, rather than upper, limits of adiposity. Since survival (rather than viability) is the evolutionary imperative, corpulence represents a 'fitter' state than does excessive leanness, which is associated with reduced reproductive function and, potentially, death. Teleologically, it is vital that detection of and response to periods of negative energy balance be safeguarded by a hardwired system that prevents starvation to guarantee survival. Unfortunately, the requisite rigidity of this system, while under strong selective pressure in a world of feast and famine, can be maladaptive in the modern age of caloric abundance, facilitating a chronic positive energy balance and consequent obesity.
Ultimately, this need-detection and response enactment is coordinated by the CNS in reaction to information from the periphery 3 . Episodic signals, associated with phasic oscillations in short-term energetic state (for example, before, during and after a meal), mediate the acute consummatory indices of hunger and satiety and adaptive thermoregulatory and metabolic aspects of energy expenditure, while chronic energetic state is reflected in tonic signaling from hormones positively correlated with adiposity 3, 4 . Thus, long-term energetic indicators define a homeostatic tone to which the episodic modulation of acute energy balance is set. Overall energetic state, and hence body weight, is determined by the integration of these afferent signals at discrete sensory nodes within the brain. Located primarily in the hypothalamus and brainstem, such populations represent interoceptive entry points into hierarchical networks that collectively provide an awareness of energetic state and modulate feeding behavior, energy expenditure and metabolism accordingly 3 .
Deconvolving the circuitry that underlies this control has been a process driven principally by technological advance. The lesion studies of the mid-twentieth century defined the gross neuroanatomical architecture of energy balance networks, while the subsequent genetic era offered insight into the cellular populations and molecular substrates that define overall system functionality. Current understanding of the central melanocortin system epitomizes this evolution and provides a conceptual blueprint for the hardwired control of energetic state. Here we consider the present view of melanocortinergic energy homeostasis with a particular focus on second-order neuronal populations defined by their expression of the melanocortin-4 receptor (MC4R).
The central melanocortin system
Central melanocortinergic control of energy balance is predicated on an ability to distinguish current and acceptable energetic values, and subsequent rectification of any discrepancy through appropriate physiological and behavioral responses. This sensory function is provided by two counteracting populations of interoceptive neurons in the arcuate nucleus of the hypothalamus (ARC) 4, 5 . ARC neurons expressing agouti-related peptide (AgRP) and coexpressing neuropeptide Y (NPY) and GABA represent the anabolic arm of the melanocortin pathway, robustly stimulated by caloric insufficiency 6, 7 and necessary for driving energy intake, conserving energy expenditure r e v i e w and promoting weight gain [8] [9] [10] . By contrast, the catabolic interests of the system are defended by ARC neurons expressing proopiomelanocortin (POMC), which, in response to caloric sufficiency, promote a cessation of feeding, increased energy expenditure and weight loss 9, 11, 12 . The sensory capacity of ARC AgRP and ARC POMC neurons is contingent on their sensitivity to afferent inputs, both neuroendocrine and neural, that communicate acute and long-term energetic state (for review, see refs. 3, 4) . In rodents with ad libitum access to food, these signals oscillate in accordance with diurnal rhythm, such that the negative energy state fomented over the course of an animal's inactive period (light cycle) is redressed through food consumption during the active period (dark cycle). This flux in energy state is reflected in the in vivo electrical activity of genetically identified ARC AgRP and ARC POMC neurons, which exhibit a respective increase and decrease in action potential firing with mounting caloric deficiency 13 . Thus, consistent with their metabolic functions, the activity of ARC AgRP and ARC POMC neurons conveys a real-time awareness of energetic need, which in turn predicts neurotransmitter release and apposite physiological output.
Functionally, both AgRP and the bioactive products of POMC processing, α-, β-and γ-melanocyte stimulating hormone (MSH), act as neuropeptides that engage cognate receptors on second-order postsynaptic targets 4, 5 . Of five G-protein-coupled melanocortin receptors in the mammalian genome 14 , only the melanocortin-3 receptor and MC4R are represented in the CNS. A definitive role for the melanocortin-3 receptor in energy balance remains to be fully clarified and will not be discussed here (for review, see ref. 15 ). The MC4R is activated principally by α-MSH, leading to neuronal depolarization and action potential firing, while AgRP acts as an antagonist or biased agonist promoting neuronal hyperpolarization (see below). Central administration of MC4R agonists promotes satiety, energy expenditure and weight loss. MC4R antagonists increase food intake, energy conservation and weight gain 4, 5 . Thus, the diametric functionality of ARC AgRP and ARC POMC neurons acting at downstream MC4R neurons underscores a bimodal system highly sensitive to fluctuations in energetic state.
Concordant with the catabolic function of α-MSH, genetic Pomc and Mc4r nullizygosity in mice [16] [17] [18] , and the inactivating POMC and MC4R mutations in humans [19] [20] [21] result in early-onset obesity defined by hyperphagia and reduced energy expenditure. Genetic ablation of the mouse Agrp locus does not engender the expected hypophagic and lean phenotype 22 , most likely because of developmental redundancy. However, postnatal cytotoxic ablation of ARC AgRP neurons does result in hypophagia and leanness [23] [24] [25] , while postnatal ARC POMC neuron ablation promotes hyperphagia and obesity 25 . Together, these studies cogently demonstrate that the melanocortin ligands are critical to mammalian energy balance.
Modern neuroscience technologies now enable the real-time manipulation of genetically defined neuronal populations, without the confounding effects of developmental compensation or pharmacological non-specificity 26 . Chemogenetic 10, 27 and optogenetic 8, 28 activation of ARC AgRP neurons in calorically replete mice rapidly (within minutes) promotes voracious food seeking and consumption and an attenuation of energy utilization, which under chronic conditions drives weight accrual 10 . Conversely, chemogenetic silencing of ARC AgRP neurons engenders hypophagia in calorically deplete mice homeostatically motivated to eat 10, 27 . Thus, ARC AgRP neurons are sufficient to drive an energy-saving motor program and are necessary for the enactment of deficiency-related feeding behaviors, including associated risk assessment and food seeking 29 .
The orexigenic function of inhibitory ARC AgRP neurons is served by the silencing of second-order satiety neurons. Although ARC AgRP neurons inhibit ARC POMC neurons 9, 30 , this is not a mechanism by which they promote acute feeding 9 . Thus, the functional antagonism of these first-order populations is defined by their convergence at common second-order targets. In accordance, neuroanatomical tracing of ARC AgRP and ARC POMC efferents reveals highly comparable projection profiles 31, 32 . Circuit-level use of optogenetics to experimentally isolate discrete ARC AgRP projections demonstrates that these neurons drive feeding through their (noncollateralized) projections to the anterior bed nucleus of the stria terminalis, lateral hypothalamus and paraventricular nucleus of hypothalamus (PVH), and to a lesser extent the paraventricular nucleus of the thalamus 28 . Pertinently, MC4R expression is closely correlated with these projections to the anterior bed nucleus of the stria terminalis, PVH and lateral hypothalamus [33] [34] [35] .
Although ARC POMC neurons project to the same regions, their explicit wiring architecture, including which circuit-specific efferents are sufficient to promote satiety, is as yet unknown. Furthermore, the rapid temporal dynamics of ARC AgRP neuron-driven feeding contrasted with the far slower effects of ARC POMC neuron-driven satiety. Both chemogenetic 11 and optogenetic 8 stimulation of ARC POMC soma produces a late-onset hypophagic response, evident only after many hours of stimulation, and body weight loss. Similarly, chemogenetic silencing of these neurons augments long-term food intake but has no acute hyperphagic effect 9 . The explanation for the apparent temporal variance in ARC AgRP and ARC POMC neuron-regulated appetite is unclear but is likely attributable to their respective neurotransmitter complement and synaptic organization.
The acute consummatory effect of ARC AgRP neurons is contingent on the release of GABA and/or NPY 9, 36 . The concerted genetic inactivation of these two ARC AgRP neuron systems (through ARC AgRP neuron deletion of vGat (Slc32a1) and global Npy nullizygosity) abolishes chemogenetic ARC AgRP neuron-driven feeding 36 , although in isolation neither mutation is functionally sufficient, suggesting that in a constitutive genetic context these two axes exhibit operative redundancy. Indeed, in Npy −/− mice ARC AgRP →PVH GABAergic synaptic strength is potentiated, indicating some level of compensatory developmental rewiring 9 . In a developed neural system, however, pharmacological blockade of GABA or NPY signaling specifically in the PVH (at GABA A receptors and Y1 receptors, respectively) independently abolishes optogenetic ARC AgRP →PVH-driven feeding 9 , implying that both systems are required, and potentially cooperate 37 , to inhibit satiety-promoting PVH neurons. Unlike the rapid orexigenic effect of centrally infused NPY, AgRP administration is effective only after a number of hours 38 . In accordance, AgRP, acting at downstream melanocortin receptors, is dispensable for rapid chemo-and optogenetically induced feeding but is required to drive late-onset, longer term consumption 8, 36 . Similarly, the slow-to-build anorectic effect of ARC POMC neurons is contingent on melanocortin receptor availability 8 . Thus, the rapid feeding induced by ARC AgRP neurons is defined by their release of fast-acting neuroactive substances, while AgRP and α-MSH signaling at downstream MC4Rs defines a slower behavioral output.
The absence of a fast-acting neurotransmitter or neuropeptide potentially explains the lack of an acute satiety effect from ARC POMC neuron activation. However, several histological studies have identified GABAergic and glutamatergic subsets of ARC POMC neurons. These studies indicate that approximately 40% of ARC POMC somata are GABAergic, as defined by their expression of the GABA synthesis npg r e v i e w genes Gad65 and Gad67 (refs. 39-41) , although they do not express the vesicular GABA transporter (vGAT) 40, 42 , suggesting that if these cells do release GABA an alternative transporter might be required for vesicular packaging. There is also evidence of a distinct glutamatergic ARC POMC subpopulation, though its reported relative proportion varies from 10% (refs. 40,42) to 50% (ref. 39 ) depending on the labeling technique employed. At present, the functional significance of these subpopulations remains uncertain and may be defined by both circuit and physiological specificity that has not yet been investigated. As an example, stoichiometric analysis of ARC POMC →PVH synapses revealed approximately 50% to be glutamatergic but only 10% GABAergic 43 (although the use of vGAT as a marker of GABAergic terminals may underestimate the number of GABA-releasing synapses; see above). Ultrastructural modeling of melanocortinergic projections to the PVH demonstrated that, while ARC AgRP neurons form symmetric and predominantly axo-somatic synapses at PVH neurons, ARC POMC →PVH neurons exhibit relatively weak and distal axodendritic connections 43 . Consistent with this, channelrhodopsinassisted circuit mapping 44 , which serves as the gold standard for the identification of functional fast neurochemical synapses, identified robust monosynaptic GABAergic connectivity from ARC AgRP to approximately 50% of PVH neurons, while ARC POMC derived postsynaptic currents were limited to only 5% of PVH neurons (3% excitatory and 2% inhibitory) 43 . Thus, in contrast to ARC AgRP neurons, which demonstrate relative homogeneity, a cofunctional and consistent peptidergic and GABAergic nature and robust synaptic organization (at least in the PVH), ARC POMC neurons exhibit neurochemical heterogeneity, a paucity of functional fast neurochemical connections and weak synaptic inputs (at least in the PVH). While these observations likely explain the slow-to-build effect of ARC POMC -driven satiety, it may also suggest the involvement of a more complex neural mechanism underlying melanocortinergically regulated satiety. For instance, it is possible that α-MSH release from ARC POMC neurons promotes synaptic restructuring and the modulation of fast transmitter inputs, such as has been observed in other melanocortinergic projections 45, 46 . Furthermore, while ARC POMC -neuron fast neurotransmitter synapses may not be required for the acute regulation of appetite, it remains to be investigated whether they play a more substantive role in other aspects of melanocortinergic physiology, such as autonomic outflow or glucose homeostasis.
The melanocortin-4 receptor
Mouse models of MC4R function. Concordant with its neuroanatomical distribution [33] [34] [35] and myriad pharmacological observations 4, 15 , ablation of the mouse Mc4r locus produces a profound dysregulation of energy homeostasis, leading to overt early-onset obesity 16 (Table 1) . Mc4r insufficiency promotes hyperphagia, reduced energy utilization, increased fat mass, perturbed glucose homeostasis and sympatho-supression 16, 47, 48 . The ad libitum hyperphagia engendered by Mc4r nullizygosity is defined by exaggerated dark-cycle consumption 49 and correlated with an increased motivation to attain food, suggesting enhanced goal-directed behavior 50 . The fidelity of the diurnal eating pattern and the normal response of Mc4r −/− mice to periods of calorie restriction 47 imply that sensory processing of hunger cues, likely at ARC AgRP neurons, remains intact in these mutants. Thus, consistent with later studies 8, 36 , the acute drive to consume food in response to energetic depletion is independent of AgRP→ MC4R signaling and is maintained in these mutants presumably as a result of the continued efficacy of ARC AgRP neuron NPY and GABA release. Protracted within-meal consumption is therefore likely to be explained by a failure of α-MSH induced satiety. In agreement, Pomc deficiency 17, 18 recapitulates most of the Mc4r −/− phenotype, including obesity, increased axial length and hypersensitivity to an obesogenic diet. Furthermore, human null mutations in either MC4R 19, 20, 51, 52 or POMC 21 lead to syndromic obesity that mirrors the respective mouse phenotype, cogently highlighting the phylogenetic conservation of this system. While these global knockout lines demonstrate the importance of MC4R signaling to the control of energy balance, the specific neural populations accountable for the pleiotropic nature of the Mc4r −/− phenotype remained unknown. The generation of two conditional Cre recombinase-dependent Mc4r alleles was fundamental to the neuroanatomical dissection of MC4R function ( Fig. 1 and Table 2 ). To assess functional sufficiency, a reactivatable Mc4r null allele was generated through the insertion of a Cre-dependent loxP-flanked transcriptional blocking sequence (Mc4r loxTB/loxTB ) 53 . Necessity was addressed with a complementary Mc4r loxP/loxP inactivation allele 54 (Fig. 1) . In the presence of an appropriate Cre-expressing driver line, these alleles are reactivated or deleted, respectively, in a molecularly defined fashion (Tables 1 and 2 54 . Re-expression or deletion of MC4Rs on GABAergic neurons has no discernible phenotypic effect 54 . Thus, whatever the identity of the MC4R neurons responsible for the pleiotropy of the Mc4r −/− mouse, they are most likely glutamatergic.
Although CNS MC4Rs have been the predominant focus for energy balance research, recent work has highlighted the contribution of MC4Rs in enteroendocrine L-cells of the intestine. These have been demonstrated to (i) regulate luminal electrolyte secretion, to potentially reduce gastric motility and enhance between-meal satiety, and (ii) promote release of the episodic satiety factors glucagon-like peptide-1 (GLP1) and peptide YY (PYY), potentially enhancing centrally mediated MC4R satiety 55 . The functional significance of these observations remains unknown, but is noteworthy given the correlation between MC4R signaling and the weight-loss efficacy of bariatric surgeries 56, 57 .
Energy intake. Pharmacological studies have been critical in directing genetic dissection of the melanocortin system. While MC4Rs in numerous sites are neuroanatomically positioned to promote satiety, at least when pharmacology probed 38, 58, 59 , it is the PVH that has garnered the most attention. Highlighted by the importance of the PVH to energy homeostasis 60 and robust MC4R expression 35, 53 , microinjections of α-MSH or AgRP into this region engender satiety and hunger, respectively, at levels beyond that seen at any other site 61 , suggesting that PVH MC4Rs represents a point of functional convergence for counteractive ARC AgRP and ARC POMC neurons.
The ontology of the PVH is defined by the transcription factor Single-minded 1 (Sim1). Developmental haploinsufficient Hyperphagic.
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Hyperglycemic and hyperinsulinemic from 5 weeks of age Normotensive Increased axial length 53, 82 (continued) npg r e v i e w 53 . Remarkably, this reduction in body weight is defined by a complete normalization of feeding behavior, but no improvement in energy expenditure 53 . Sim1-CreøMc4r loxTB/loxTB mice also exhibit restored sensitivity to the hypophagic, but not hypermetabolic, effects of MTII 53 . The deletion of MC4R-expressing Sim1-positive neurons (Sim1 MC4Rs ; Sim1-CreøMc4r loxP/loxP ) results in reciprocal hyperphagia and obesity 54 . However, these mice were lighter than vGlut2-ires-CreøMc4r loxP/loxP mice, indicating that other glutamatergic MC4R populations, regulating energy expenditure, contribute to body weight. Therefore, Sim1 MC4Rs neurons are both sufficient and necessary for the physiological control of homeostatic feeding and body weight, but not energy expenditure, indicating a functional divergence in the energy-balance melanocortinergic circuitry. Although these effects were attributed to MC4R expression in PVH SIM1 neurons, allelic recombination in other brain areas demarked by Sim1-Cre expression 53 or unobserved developmental compensatory mechanisms could contribute to the observed phenotypes. To circumvent these obstacles, postnatal specific recombination was achieved through the stereotaxic injection of a Cre-expressing adeno-associated virus (AAV-Cre) into distinct neuroanatomical structures of adult Mc4r loxTB/loxTB and Mc4r loxP/loxP mice. Consistent with the Sim1-CreøMc4r loxP/loxP phenotype, AAV-Cre deletion of PVH MC4Rs results in hyperphagia, increased adiposity and obesity 54 , while PVH-specific Mc4r re-expression in Mc4r loxTB/loxTB mice reciprocally reduces the obesity and hyperphagia associated with Mc4r nullizygosity 53, 54 . In contrast, rescued Mc4r expression in the medial amygdala 54 , the lateral parabrachial nucleus (LPBN) 54 , the nucleus of the solitary tract (NTS) and dorsomedial nucleus of the vagus (DMV) 54 , or the lateral hypothalamus 66 has no effect on feeding behavior. Thus, PVH Sim1øMC4Rs are the main component of MC4R-regulated satiety.
To further refine the neurochemical subtype of energy-balanceregulating PVH MC4R neurons, a battery of knock-in Cre-expressing mice, demarking specific subpopulations of PVH neurons, was used to determine the sufficiency of Mc4r reactivation in a neurochemically explicit manner. Re-expression of MC4Rs in neurons expressing corticotropin-releasing hormone (Crh-ires-Cre) and/or oxytocin (Oxt-ires-Cre), arginine vasopressin (Avp-ires-Cre) or pro-dynorphin (Pdyn-ires-Cre) does not reduce body weight 54 , suggesting that MC4Rs expressed on any one of these populations alone does not contribute to energy homeostasis. However, regardless of the uncertain neuropeptidergic identity of PVH Sim1øMC4R neurons, it is likely that their body-weight-regulating function is primarily contingent on their release of glutamate, since re-expression of Mc4r and concomitant deletion of vGlut2 in Sim1 neurons nullifies the improvement in Sim1-CreøMc4r loxTB/loxTB phenotype 67 .
As yet, the only other population of MC4Rs to be genetically implicated in the regulation of feeding are those demarked by a dopamine-1 receptor (Drd1)-Cre line 49 . Drd1-CreøMc4r loxTB/loxTB mice exhibit a small reduction in hyperphagia (but no improvement in energy expenditure) that results in a 10% decrease in body weight 49 . While the specific population of Drd1 MC4R expressing neurons responsible for this phenotype remains to be determined, it is possible that partial npg r e v i e w coexpression (and subsequent reactivation) 68 in the PVH contributes to this mild improvement in energetic balance. 70 . On the basis of pharmacological data, it is possible that MC4Rs expressed in the median pre-optic nucleus and/or DMH may contribute to some elements of melanocortin-regulated energy expenditure 71 . The role of ChAT MC4Rs neurons in energy expenditure is most readily observed in the adaptive response to environmental challenge, such as exposure to a high-calorie diet (HCD) or a cold environment. Wild-type mice presented with a HCD exhibit hyperthermia and increased energy expenditure that restrain body weight gain; Mc4r −/− and Chat-ires-CreøMc4r loxP/loxP mice, by contrast, fail to enact these adaptive responses 47, 70 . Mechanistically, this elevation in body temperature is mediated by brown adipose tissue (BAT), which is potently activated by the sympathetic nervous system (SNS) and a vital component of melanocortinergic adaptive thermogenesis 47, [72] [73] [74] . SNS outflow to BAT promotes mitochondrial uncoupling, leading to proton leakage and the generation of heat. This process depends on mitochondrial uncoupling protein-1 (UCP1) 75 . Both Mc4r −/− and Chat-ires-CreøMc4r loxP/loxP mice fail to upregulate UCP1 expression in response to a HCD, suggesting that compromised MC4R-mediated SNS outflow to BAT 70 contributes to their sensitivity to an obesogenic diet. Although UCP1 expression can also be regulated by the hypothalamic-pituitary-thyroid axis, this system is not a functional target for the MC4R dietary response, since Mc4r −/− mice exhibit normal thyroid hormone levels and apposite thyroid responses to a HCD 72 . Acute cold exposure similarly engenders SNS-regulated BAT-mediated thermogenesis that is required for maintaining core body temperature. In this regard it would seem that MC4Rs do not contribute, since two separate studies found Mc4r −/− mice to exhibit normal basal body temperature in ambient conditions and apposite thermogenic responses to cold exposure 47, 48 .
Autonomic outflow to white adipose tissue (WAT), the silo for excess caloric energy, is important in regulating lipid metabolism and composition 76 . Sympathetically mediated 'beiging' of BAT-like progenitors in WAT has been proposed as an adaptive response to environmental stressors, such as cold exposure and obesogenic diet 77 . This evoked development of UCP1-expressing beige cells elevates body temperature and energy expenditure. Central MC4R-expressing neurons in several sites are anatomically connected to WAT 78 . Notably, cold-exposed Mc4r −/− and Chat-ires-CreøMc4r loxP/loxP mice, but not Phox2b-CreøMc4r loxP/loxP mice, fail to show evidence of beiging 70 , suggesting that MC4R-regulated SNS outflow to WAT is required for the induction of this adaptive response. Whether a similar mechanism underlies diet-induced beiging remains to be determined. Real-time chemogenetic activation of ARC POMC neurons drives an SNSdependent beiging effect 12 , implicating an ARC POMC →IML MC4R circuit in this process.
Glucose homeostasis.
Mc4r deficiency in mice is associated with hyperglycemia and hyperinsulinemia that precede the onset of obesity but are exacerbated by fat accrual 16, 48, 79 . By contrast, human MC4R deficiency results in euglycemic hyperinsulinemia during childhood but a normalization of insulin levels during adulthood, with no manifestation of diabetes 51, 52, 80 . Thus, it would seem that at least the initiating hyperinsulinemic state is conserved in the mouse and human condition, with onset of diabetes in adult Mc4r −/− mice potentially defined by subsequent body-weight-dependent insulin resistance. Furthermore, congenic strains of Mc4r −/− mice, while still being obese, do not exhibit hyperglycemia or hyperinsulinemia 81 , suggesting that there is a role for strain-specific (body-weight-independent) 70 . Together these results suggest that that preganglionic parasympathetic Phox2b MC4Rs suppress PNS outflow to inhibit pancreatic insulin release, but that this does not influence overall glycemic state or insulin sensitivity, while preganglionic sympathetic ChAT MC4Rs do not directly influence insulin release but do set general glycemic tone.
Given that PNS outflow stimulates insulin release, this implies that MC4Rs inhibit rather than activate DMV neurons. Indeed, MC4R agonists cause hyperpolarization at most DMV ChAT neurons 82 (see below). Thus, global or DMV-specific Mc4r deficiency results in exaggerated PNS outflow to the pancreas and hyperinsulinemia. However, the role of ChAT MC4Rs is seemingly more complex. Specifically, given the stimulatory effect 82 of IML MC4Rs , and given that SNS outflow promotes glucose production and excursion, it is surprising that the sympatho-suppressed state of Mc4r −/− and Chat-ires-CreøMc4r loxP/loxP mice actually drives a sympathoexcitatory phenotype (increased glucose excursion and reduced glucose disposal) 70 . It is possible that it is in fact body composition that is the main defining factor in this phenotype, such that the mildly reduced body weight of Chat-ires-CreøMc4r loxTB/loxTB mice 69 and the obesity of Chat-ires-CreøMc4r loxP/loxP mice 70 explains their improvement and deterioration in glycemic state, respectively. This notion is supported by the normoglycemia exhibited by Mc4r −/− mice pairfed to wild type levels 48 and ad libitum fed Sim1-CreøMc4r loxTB/loxTB mice 53 , which have reduced body weight. However, it is likely that the MC4R is involved in least some element of glycemic control, independently of its body weight effects, since AAV-Cre mediated Mc4r re-expression in the lateral hypothalamus mildly improves SNS-dependent glucose tolerance (but not basal glycemic state) in adult Mc4r loxTB/loxTB mice, without altering body weight or composition 66 .
Additional autonomic functions. Central administration of α-MSH
elevates blood pressure and heart rate in an SNS-and MC4R-dependent manner 83, 84 . This corollary of wholesale MC4R activation has significantly hampered the development of MC4R-based weight-loss pharmacotherapies 85 . Consistent with an MC4R pressor effect, Mc4r −/− mice exhibit paradoxical normotension and tachycardia, despite being obese, hyperinsulinemic and hyperleptinemic 86 . However, the re-establishment of autonomic tone in Chat-ires-CreøMc4r loxTB/loxTB mice unmasks a hypertensive phenotype in accord with their obese state 82 , suggesting that direct MC4R engagement of preganglionic autonomic neurons underlies their regulation of cardiovascular function. In obese MC4R-deficient humans, most of whom are similarly normotensive and tachycardic 80 , there is evidence of both PNS and SNS involvement, consistent with MC4R nullizygosity engendering both parasympatho-excitation and sympatho-suppression (for review, see ref. 87 npg r e v i e w phenotypes are defined by generalized sympatho-suppression. Indeed, pharmacological blockade of central MC4R signaling engenders an increase in respiratory quotient, WAT lipid content and lipogenic gene expression in an SNS-dependent, but body-weight-independent, manner 92 . Furthermore, MC4R engagement of the parasympathetic nervous system regulates hepatic cholesterol uptake such that genetic or pharmacological inactivation of central murine 93 (but not human 80 ) MC4R signaling elevates circulating levels of cholesterol and high density lipoprotein:cholesterol complexes. Thus, MC4R-regulated autonomic tone influences nutrient handling and lipid metabolism independently of obesity to contribute to metabolic fitness.
PVH MC4R neural circuitry. Conditional genetic manipulations have been fundamental to defining the neuroanatomical landscape of Mc4r-regulated physiology. However, the neural interactions underlying functional outflow can only be resolved through the application of circuit-level cellular technologies. Unlike pharmacological and germline genetic approaches, such tools do not directly address the contribution of an individual molecular component, but rather provide insight knockout cardiovascular phenotype remains unexplored. Despite the preautonomic role of the PVH and the mild pressor effect observed upon intra-PVH agonist infusion [88] [89] [90] , Sim1 MC4R re-expression does not cause hypertension. However the non-obese nature of these animals may mean that, even if autonomic tone were partially rescued (which remains unknown), there is no initiating pathology to drive hypertension 82 . Dissociating the neural mechanisms underlying the MC4R pressor effect will be critical for the generation of energybalance-regulating MC4R compounds devoid of cardiovascular side effects for the safe and effective treatment of obesity. Further to its effects on WAT composition, MC4R-regulated ANS outflow modulates peripheral lipid metabolism to influence the deposition and circulation of fat. Mc4r-and MC4R-deficient mice 91 and humans 92 exhibit elevated respiratory quotients, indicative of a shift from fat utilization to fat storage. This perturbation in substrate utilization exacerbates adipose tissue expansion and weight gain beyond that defined simply by a net positive energy balance. In light of MC4R expression in preganglionic IML neurons 69 , as well as in preautonomic outflow neurons innervating WAT 78 , it is likely that these are the predominant energy-intake-regulating population (and also govern body length) but do not influence energy expenditure. These neurons receive monosynaptic inhibitory input from ARC AgRP neurons and are necessary for the full ARC AgRP →PVH feeding phenotype. Real-time optogenetic interrogation identified the LPBN as the site of functional outflow for appetite-regulating PVH MC4R neurons. Furthermore, PVH MC4R →LPBN satiety carries a positive valence, contrasting the negative valence associated with hunger-promoting ARC AgRP neurons. PVH MC4R →LPBN neurons are depolarized by an MC4R agonist, suggesting that they are activated by upstream satiety-promoting ARC POMC neurons, although this remains to be proven (blue line). A subtractive conditional genetic approach has implicated Mc4r expression on preganglionic parasympathetic neurons of the DMV in the tonic inhibition of pancreatic insulin release but not overall glycemic state or energy expenditure. MC4Rs on preganglionic sympathetic neurons of the IML govern overall sympathetic tone, leading to increased energy expenditure, hypertension and decreased glucose output. Red, ARC AgRP →PVH MC4R satiety pathway; green, vagal afferents; purple, spinal afferents; yellow, parasympathetic nervous system; magenta, sympathetic nervous system; question mark, neuronal population of unknown identity. AgRP, agouti-regulated peptide; ARC, arcuate nucleus of the hypothalamus; CCK, cholecystokinin; CV, cardiovascular; DMV, dorsal motor nucleus of the vagus; FFA, free fatty acids; GHR, ghrelin; GLP1, glucagon-like peptide-1; IML, intermediolateral nucleus of the spinal cord; LPBN, lateral parabrachial nucleus; NG, nodose ganglion; NTS, nucleus of the solitary tract; MC4R, melanocortin-4 receptor; POMC, pro-opiomelanocortin; PVH, paraventricular nucleus of the hypothalamus; SC, spinal cord. Fig. 1 ) expressing that component.
Consistent with role of PVH MC4Rs in the regulation of energy intake 53, 54 chemogenetic activation of Cre-expressing PVH MC4R neurons promotes satiety during times of physiological hunger, indicating that they are neuroanatomically positioned to suppress homeostatic feeding 35 . Activation of PVH MC4R neurons has no effect on energy expenditure, validating prior genetic observations 53 . Loss-of-function studies further demonstrate that these neurons are necessary for the maintenance of satiety, such that their inactivation during times of caloric sufficiency results in increased goal-directed light-cycle food consumption 35 . Given the functional reciprocity of the melanocortin ligands, the bidirectionality of PVH MC4R -regulated appetite supports their position as a point of functional convergence for inhibitory feeding-promoting ARC AgRP neurons and excitatory satiety-promoting ARC POMC neurons. Indeed, channelrhodopsinassisted circuit mapping demonstrates that the vast majority of PVH MC4R neurons receive GABAergic input from ARC AgRP neurons and that this interaction is necessary for ARC AgRP →PVH-driven feeding. However, the rapid feeding effects engendered by ARC AgRP →PVH photostimulation or artificial PVH MC4R manipulations do not necessarily speak to the explicit function of MC4Rs. In this regard, beyond their expression of a cognate receptor and sensitivity to selective pharmacological agonists 35 , the functional role of endogenous AgRP or α-MSH at PVH MC4R neurons remains to be determined. It will be important to further refine the position of PVH MC4R neurons downstream of ARC POMC neurons, since this is the circuit that ultimately defines satiety.
Sites of functional outflow for PVH MC4R neurons were identified through efferent projection mapping 35 . Since glutamate release is critical to the function of PVH MC4R neurons 54, 67 , putative postsynaptic cells in efferent sites were assayed for excitatory monosynaptic connections arising from presynaptic PVH MC4R neurons. Despite a broad descending projection profile, glutamatergic connections were identified only in the LPBN and DMV, implicating these site as prospective third-order nodes involved in feeding regulation 35 . Connected LPBN neurons are located specifically in the central compartment (cLPBN). In vivo optogenetic stimulation of PVH MC4R →cLPBN terminals, but not those in DMV or ventrolateral periaqueductal gray, promotes satiety, confirming this structure as site of functional outflow for melanocortin-regulated appetite. In this regard, the role of the LPBN as an interoceptive rely 94 befits its role in appetite regulation. LPBN lesions induce hyperphagia and obesity 95 , and hyporesponsivity to anorectic neuroendocrine factors 96 . Input from ascending sensory afferents (both vagal, via NTS, or spinal) 94 , in addition to a direct chemosensing capacity 97, 98 , influences LPBN neuron activity in a viscerotopic fashion. Thus, it is possible that a neurochemically defined satiety population or populations integrates both ingestion-related visceral stimuli and hypothalamically derived homeostatic information to jointly determine behavioral and physiological responses to food consumption. The explicit identity of the cLPBN satiety population engaged by PVH MC4R neurons remains unknown, but it is glutamatergic, as LPBN vGLUT2 neurons are necessary for the realtime maintenance of satiety and are selectively engaged by PVH MC4R neurons 35, 54 . Furthermore, these satiety cLPBN neurons are distinct from appetite-suppressing calcitonin-gene related peptide (CGRP)-expressing neurons in the external LPBN (eLPBN). eLPBN CGRP neurons inhibit food consumption under conditions in which it is unfavorable to eat (such as sickness) 99 and a carry negative valence when optogenetically activated 100 . That satiety-promoting PVH MC4R →cLPBN neurons do not engage eLPBN CGRP neurons demonstrates how specific neuroanatomical circuits subserve the context-specific regulation of food intake.
In its most simplistic biological form, appetite is a function of energy requirement. The physiological representation of this caloric need is recognized as hunger, the detection of which ensures the motivation to enact behaviors that lead to food consumption (Fig. 2a) . Recent work has demonstrated that the motivation to engage in these behaviors is driven by the aversive nature of hunger, as represented by ARC AgRP neuron activation 101 , which promotes a negative physiological state that is alleviated upon caloric intake 102 . Thus, the consumption of food, and hence satiety, is reinforcing to ensure the motivation required to respond to periods of caloric deficiency. Supporting this, experimentally induced satiety through optogenetic stimulation of PVH MC4R →LPBN terminals 35 (or chemogenetic silencing of ARC AgRP neurons 101 ) encodes a positive valence that hungry mice preferentially seek out, essentially alleviating their hunger through self-stimulation of this neural circuit (Fig. 2b) . Remarkably, the positive valance encoded by ARC AgRP neuron silencing and PVH MC4R neuron activation in hungry mice is energy-state dependent, such that in calorically sated mice the activation and silencing of these populations, respectively, no longer represents a preferential state (Fig. 2c) 35, 101 .
In experimentally distilling the motivational basis of feeding behavior, these complementary studies demonstrate, consistent with early theories concerning need states and their homeostatic rectification 103, 104 , that the motivation to enact the behaviors (food-seeking and consumption) that fulfill an unmet need (caloric insufficiency) is driven by the negative valence of the physiological state (hunger) and that reestablishment of homeostasis encodes a positive valence associated with relief from this state. It is tempting to speculate that the unpleasant feelings associated with hunger, combined with the relief, if not pleasure, that comes from subsequent food consumption, is one of the main reasons why dieting proves so difficult. Specifically, the motivational incentive to respond to periods of hunger (a state exaggerated by dieting) has evolved to be a robust and unerring survival drive, the disregard of which is difficult. Consequently, the therapeutic activation of a system that encodes both satiety and positive valence (such as PVH MC4R →LPBN) could conceivably serve as a potent adjunct to caloric restriction for the treatment of obesity.
MC4R signal transduction.
The physiological functions of the MC4R are ultimately defined by the intracellular mechanisms that transduce ligand-receptor interactions into neuronal excitability. Although originally defined as a Gα s -coupled receptor, recent investigation into the nature of the binding of α-MSH and AgRP to MC4Rs have revealed the diversity of signaling cascades engaged by their orthosteric binding 105 . Depending on cellular context, application of MC4R agonists promotes G s -dependent cyclic AMP synthesis 106 , G q -dependent phospholipase-C activity 107 and G-protein-dependent MAPK signaling [108] [109] [110] . However, these studies relied on heterologous in vitro systems, and thus their extrapolation to in vivo relevance is uncertain. In probing transgenically labeled PVH MC4R neurons in ex vivo slice preparations, a recent study revealed that α-MSH agonism, and subsequent neuron excitation, is mediated by the closure of the inwardly rectifying potassium channel Kir7.1, in a G-protein-, β-arrestin-and MAPK-independent manner 111 . However, this mechanism is celltype specific, as the inhibitory action of α-MSH at DMV MC4R neurons is contingent on G s -mediated activation of an ATP-dependent potassium channel 82 . The relevance of these mechanisms to MC4R-regulated physiology remains to be determined, but genetic ablation of the Gsα (Gnas) coding region in mice, while not specific to npg r e v i e w MC4R, leads to profound syndromic obesity that is associated with reduced energy expenditure and sympathetic outflow, independent of hyperphagia 112 . Targeted deletion from Sim1 neurons promotes only mild obesity with no influence on feeding behavior 113 . These observations may suggest that MC4R coupling to Gα s in the PVH is not a functional requirement for the regulation of feeding behavior, potentially identifying a role for Gα q or G-protein-independent Kir7.1 signaling. Together these data indicate that the MC4R is likely to exhibit promiscuous coupling to multiple intracellular mediators in a physiology-specific context. α-MSH signaling is potentiated by the actions of a conserved family of melanocortin receptor accessory proteins (MRAPs). The murine 114 and teleost 115 isoforms of MRAP2 sensitize the MC4R to α-MSH binding and augment signal transduction. In mice, the global or Sim1-specific deletion of the sole MRAP2 paralog results in late-onset obesity that is, paradoxically, not defined by hyperphagia or reduced energy expenditure (nor reduced anorectic sensitivity to MTII) 114 .
The melanocortin system is unique in possessing a second, counteracting ligand in the form of AgRP. Initial pharmacological observations of AgRP function led to its characterization as an MC4R antagonist, serving to block α-MSH agonism [116] [117] [118] . AgRP has also been identified as an inverse agonist, operating independently of α-MSH to promote G-protein uncoupling at constitutively active MC4Rs [119] [120] [121] [122] . However, the physiological significance of constitutive MC4R activity in vivo is unclear 123 . Most recently AgRP has been identified as a biased agonist, directly promoting membrane hyperpolarization independently of constitutive activity or agonist presence. This mechanism has been observed in both a G-protein-dependent and G-protein-independent manner. In a heterologous cell system, AgRP binding selectively recruits G i/o , leading to reduced cAMP accumulation 124 , while in ex vivo PVH MC4R neurons, AgRP drives G-protein-independent activation of Kir7.1 and subsequent hyperpolarization 111 . Little is yet known of the physiological significance of the MC4R-Kir7.1 interaction, but future genetic studies are likely to provide invaluable insights.
MC4R pharmacotherapy
Driven by the ever more pervasive issue of human obesity, much effort has been directed toward unraveling the neural circuits that coordinate the regulation of energy homeostasis and body weight. In fulfilling a highly conserved physiological function, the central melanocortin system sits at the intersection of obesity pathology and treatment. Nullizygous mutations in human POMC 21 and MC4R 19, 20, 52 genes engender pleiotropic obesity syndromes that are consistent with their epistatic cofunctionality. Furthermore, POMC 125, 126 and MC4R 52, 127 haploinsufficiency predisposes carriers to obesity, albeit with varying penetrance that speaks to the importance of environmental factors and genetic modifiers. Indeed, MC4R mutations represent the most prevalent form of monogenic obesity (0.5-6% of obese individuals) 52 , and MC4R variations are highly correlated with fat mass 128 . However, contrasting this pathological association is the potential of the MC4R as a pharmacotherapeutic target for obesity 129, 130 . Consistent with rodent studies, pharmacological compounds that augment MC4R signaling promote appetite suppression and weight loss in humans 130 . Unfortunately, these drugs influence other MC4R-regulated processes, such as cardiovascular tone, sexual function and pandiculation, limiting their clinical application 129 . At present only one MC4R compound, setmelanotide (RM-493; Rhythm Pharmaceuticals), is undergoing clinical trials, and only for use in the rare obesity conditions Prader-Willi syndrome and POMC deficiency. Setmelanotide reduces food intake and increase energy expenditure in several preclinical models 131, 132 . In obese rhesus macaques 132 and a small cohort of obese humans 133 , this drug had no adverse effects on blood pressure; however, the latter study reported sexual side effects 133 . Alternative strategies such as positive allosteric modulators (PAMs), which augment MC4R signaling upon orthosteric binding of α-MSH, and molecular chaperones, which increase cell surface availability of MC4Rs, are being investigated as a means of enhancing the efficacy of endogenous α-MSH to offer more physiologically relevant temporal specificity 129 .
Basic science efforts to experimentally identify the relevant neuronal populations that underlie the various physiological functions of the MC4R will be critical for the development of new obesity-specific compounds. Such studies will afford insight into the involvement of neuroanatomically discrete MC4R populations and potentially facilitate the identification of differentially expressed targets amenable to pharmacological manipulation. For instance, PVH MC4R neurons are the preponderant agent of melanocortinergic appetite control and thus a foremost target for weight-loss therapies. While explicit pharmacological manipulation of these MC4Rs is as yet impossible and confounded by drug action at MC4R populations governing autonomic outflow, PVH MC4R neurons express other potential targets not expressed in preautonomic MC4R neurons. Transcriptomic profiling will be vital for contrasting neuroanatomical populations of MC4R-expressing neurons and identifying physiology-specific targets. In addition, evidence of promiscuous MC4R intracellular coupling (see above) may also suggest that these receptors employ functionally exclusive signaling cascades. In vivo interrogation of these mechanisms may afford understanding of the signal transduction pathways that define the function of satiety-promoting MC4Rs.
Conclusions and future directions
The central melanocortin systems regulates body weight and overall metabolic fitness in a manner defined by its need-based orchestration of physiology and behavior. The initiation of these processes is contingent on the interoceptive function of counter-acting ARC AgRP and ARC POMC neurons that represent a cellular interface between afferent indicators of physiological state and neural circuits governing response enactment. The capacity of the melanocortin system to subserve both catabolic and anabolic modalities of energy balance is determined by their antagonistic engagement of secondorder MC4R-expressing neurons. While additional, non-MC4R mechanisms and populations contribute to aspects of ARC AgRP and ARC POMC functionality 35 , the phenotypic similitude arising from the experimental manipulations of these first-and second-order populations strongly supports MC4R expressing neurons as important mediators of melanocortinergic energy balance.
Conditional genetic manipulations of Mc4r expression reveal a functional divergence in the melanocortinergic circuitry, such that the regulation of specific physiologies or behaviors proceeds via neuroanatomically discrete populations of MC4R neurons (Fig. 3) . Indeed, although many MC4R populations remain unexplored, experimental interrogation of those in the PVH (feeding behavior), DMV (insulin release) and IML (energy expenditure and glucose metabolism) has demonstrated their synergistic but non-overlapping functions. The rationalization of these phenotypes in the context of the upstream melanocortinergic circuitry has subsequently been facilitated by the application of modern neuroscience technologies. Thus, explicit genetic access to MC4R neurons in combination with these techniques affords understanding of both the up-and downstream circuitry that defines physiological function. In this regard, further deconvolution of the LPBN circuitry underlying the satiety effect of PVH MC4R npg r e v i e w neurons is critical to understanding the means by which real-time fluctuations in energy state are translated into volitional behavior. The complex anatomical substructure, neurochemical composition and viscerotopic arrangement of the LPBN suggests that there is likely to be a functionally explicit population of neurons that integrates labeled lines of satiety-related homeostatic and visceral information and informs decision-making processes via its ascending projections, potentially to limbic (central nucleus of the amygdala, lateral hypothalamus, bed nucleus of the stria terminalis and cortico-thalamic structures (paraventricular nucleus of the thalamus and insular cortex). Furthermore, this homeostatic system is likely to be influenced by neural inputs that convey contextspecific information to modulate functional output in accordance with the broader state of the animal and its environment. Expansion of this aspect of the melanocortinergic circuitry will have important implications for how homeostatic processes-in particular, feeding behavior-can be influenced by factors such as stress, reward and circadian rhythmicity, and provide insight into the complexity of human energy balance.
The rising prevalence of clinical obesity, due primarily to caloric overconsumption, has highlighted the need for more efficacious pharmacotherapies. The ability of MC4R compounds to promote weight loss has long been held as evidence of therapeutic potential, yet the multiplicity of physiologies regulated by this receptor has subverted the generation of a safe and effective drug. To this end, further basic science endeavor in deconvolving MC4R biology-in particular, with regard to the neurons that express these receptors, their circuitry and intracellular cascades that define their function-is critical for streamlining pharmaceutical efforts to specifically target the bodyweight-regulating MC4R neurons.
